Molecular Diagnosis & Therapy

Papers
(The H4-Index of Molecular Diagnosis & Therapy is 24. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-08-01 to 2026-08-01.)
ArticleCitations
ADORA3: A Key Player in the Pathogenesis of Intracranial Aneurysms and a Potential Diagnostic Biomarker143
The Role of MicroRNAs in the Pathogenesis and as Biomarkers for Pediatric Epilepsy: A Systematic Review85
Predictive Ability of Serum Amino Acid Levels to Differentiate Fibromyalgia Patients from Healthy Subjects62
Marnetegragene Autotemcel: First Approval61
Comment on “Prognostic and Clinical Significance of Human Leukocyte Antigen Class I Expression in Breast Cancer: A Meta‑Analysis”60
Gene Therapy for Cardiomyocyte Renewal: Cell Cycle, a Potential Therapeutic Target43
Indirect Clinical Validation of a Programmed Death-Ligand 1 Laboratory-Developed Test for Gastric/Gastroesophageal Junction Adenocarcinoma with 22C3 Antibody Concentrate43
Considering Tumour Sidedness is Critical for Accurate Interpretation of Liquid Biopsy Results in Metastatic Colorectal Cancer43
Personalized Cancer Monitoring Assay for the Detection of ctDNA in Patients with Solid Tumors41
Expression Signature of Immune-Related MicroRNAs in Autoimmune Skin Disease: Psoriasis and Vitiligo Insights40
Evaluation of Minimal Residual Disease in Patients with Neuroblastoma37
FAPI-Targeted Molecular Imaging: Transforming Insights into Post-Ischemic Myocardial Remodeling?35
Personalized Medicine in Cystic Fibrosis: Characterization of Eight Rare CFTR Variants in Intestinal Organoids and Cellular Models35
The Role of Non-coding RNAs in Connective Tissue Diseases: Diagnostic and Therapeutic Potential of miRNAs, lncRNAs and circRNAs34
Prediction of Biomarker Expression on Primary Pancreatic Ductal Adenocarcinoma Tissues Using Fine-Needle Biopsies: Paving the Way for a Patient-Tailored Molecular Imaging Approach34
Research Progress on Signal Conversion Based on Aptamer Combined CRISPR/Cas System in Biosensors32
Drug Hypersensitivity Reactions in Patients with Cystic Fibrosis: Potential Value of the Lymphocyte Toxicity Assay to Assess Risk30
Recent Advancements in Nanomaterials: A Promising Way to Manage Neurodegenerative Disorders27
Correction to: Revakinagene Taroretcel: First Approval27
Personalizing Oncolytic Immunovirotherapy Approaches26
Fatty Acid Desaturase: The Yin or Yang of Disease Pathology26
Development of a Nomogram to Predict Therapeutic Resistance in Metastatic Melanoma Using Longitudinal ctDNA Kinetics25
Advances and Challenges in the Diagnosis of Leishmaniasis25
Inflammatory Gene Panel Guiding the Study of Genetics in Inflammatory Bowel Disease24
0.42010688781738